Outcome of APL patients in the IC-APL 2006 trial
| . | CIR . | CI of NRM . | DFS . | EFS . | OS . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient . | N . | 2-y % (95% CI) . | N . | 2-y % (95% CI) . | N . | 2-y % (95% CI) . | N . | 2-y % (95% CI) . | N . | 2-y % (95% CI) . |
| All patients | 153 | 4.5 (1.8, 9.2) | 153 | 5.3 (2.4, 9.6) | 153 | 91 (86, 95) | 183 | 77 (70, 83) | 183 | 80 (73-85) |
| Low risk | 24 | 0 | 24 | 8.9 (1.4, 25.1) | 24 | 91 (69, 98) | 30 | 79 (59, 90) | 30 | 79 (59, 90) |
| Intermediate risk | 83 | 1.2 (0.1, 5.9) | 83 | 1.2 (0.1, 5.9) | 83 | 98 (91, 99) | 95 | 86 (78, 92) | 95 | 87 (79, 93) |
| High risk | 46 | 14.1 (4.6, 28.7) | 46 | 10.9 (3.9, 21.8) | 46 | 77 (59, 88) | 58 | 59 (45, 72) | 58 | 67 (53, 76) |
| P value | 0.08 | 0.04 | 0.009 | 0.005 | 0.01 | |||||
| . | CIR . | CI of NRM . | DFS . | EFS . | OS . | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patient . | N . | 2-y % (95% CI) . | N . | 2-y % (95% CI) . | N . | 2-y % (95% CI) . | N . | 2-y % (95% CI) . | N . | 2-y % (95% CI) . |
| All patients | 153 | 4.5 (1.8, 9.2) | 153 | 5.3 (2.4, 9.6) | 153 | 91 (86, 95) | 183 | 77 (70, 83) | 183 | 80 (73-85) |
| Low risk | 24 | 0 | 24 | 8.9 (1.4, 25.1) | 24 | 91 (69, 98) | 30 | 79 (59, 90) | 30 | 79 (59, 90) |
| Intermediate risk | 83 | 1.2 (0.1, 5.9) | 83 | 1.2 (0.1, 5.9) | 83 | 98 (91, 99) | 95 | 86 (78, 92) | 95 | 87 (79, 93) |
| High risk | 46 | 14.1 (4.6, 28.7) | 46 | 10.9 (3.9, 21.8) | 46 | 77 (59, 88) | 58 | 59 (45, 72) | 58 | 67 (53, 76) |
| P value | 0.08 | 0.04 | 0.009 | 0.005 | 0.01 | |||||